Stay updated on Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Sign up to get notified when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.
Latest website image capture
Clouds background image

Latest updates to the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page

  1. Check
    4 days ago
    Change Detected
    Summary
    Added 'Squamous cell carcinoma of the head and neck' as a listed condition in the study details.
    Difference
    0.1%
    Check dated 2026-04-02T04:47:37.000Z thumbnail image
  2. Check
    11 days ago
    No Change Detected
  3. Check
    18 days ago
    Change Detected
    Summary
    Revision v3.5.0 added; revision v3.4.3 removed.
    Difference
    0.1%
    Check dated 2026-03-18T17:52:23.000Z thumbnail image
  4. Check
    26 days ago
    Change Detected
    Summary
    Revision updated from v3.4.2 to v3.4.3.
    Difference
    0.1%
    Check dated 2026-03-11T16:59:02.000Z thumbnail image
  5. Check
    54 days ago
    Change Detected
    Summary
    Added Revision: v3.4.2; removed the government funding lapse notice and the older Revision: v3.4.1 entry.
    Difference
    0.4%
    Check dated 2026-02-11T10:15:50.000Z thumbnail image
  6. Check
    61 days ago
    Change Detected
    Summary
    The page now displays a government funding lapse notice and the site version was updated to Revision: v3.4.1, which are administrative updates and do not affect core study content or user actions. To avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.4%
    Check dated 2026-02-04T06:46:40.000Z thumbnail image
  7. Check
    68 days ago
    Change Detected
    Summary
    Show glossary control added and metadata labels revised (Last Update Submitted that Met QC Criteria, No FEAR Act Data, Revision: v3.4.0) replacing the previous QC/Revision label. No core study content, eligibility criteria, or results are affected; to avoid being alerted by small changes, set an alert condition by clicking below.
    Difference
    0.2%
    Check dated 2026-01-28T04:45:22.000Z thumbnail image

Stay in the know with updates to Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial

Enter your email address, and we'll notify you when there's something new on the Pembrolizumab plus Vorinostat in Head and Neck Cancer Clinical Trial page.